Pontiano Kaleebu

Research.com Recognitions

• Fellow of The Academy of Medical Sciences, United Kingdom
• Fellow of The Academy of Medical Sciences, United Kingdom

Overview

Best Publications

• The trans-ancestral genomic architecture of glycemic traits

  Ji Chen;Ji Chen;Cassandra N. Spracklen;Cassandra N. Spracklen;Gaëlle Marenne;Gaëlle Marenne;Arushi Varshney

  853
  Citations

• HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression analysis

  Ravindra K Gupta;John Gregson;Neil Parkin;Hiwot Haile-Selassie

  487
  Citations

• Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis

  Joris Hemelaar;Ramyiadarsini Elangovan;Jason Yun;Leslie Dickson-Tetteh

  408
  Citations

• Effect of Human Immunodeficiency Virus (HIV) Type 1 Envelope Subtypes A and D on Disease Progression in a Large Cohort of HIV-1—Positive Persons in Uganda

  Pontiano Kaleebu;Pontiano Kaleebu;Neil French;Cedric Mahe;David Yirrell

  353
  Citations

• HIV subtype diversity worldwide.

  Nicholas Bbosa;Pontiano Kaleebu;Pontiano Kaleebu;Deogratius Ssemwanga;Deogratius Ssemwanga

  326
  Citations

• Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study

  John Gregson;Michele Tang;Nicaise Ndembi;Raph L Hamers

  287
  Citations

• Short-course antiretroviral therapy in primary HIV infection.

  S Fidler;K Porter;F Ewings

  286
  Citations

• Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis

  Soo Yon Rhee;Jose Luis Blanco;Michael R. Jordan;Jonathan Taylor

  282
  Citations

• Immune activation alters cellular and humoral responses to yellow fever 17D vaccine

  Enoch Muyanja;Aloysius Ssemaganda;Pearline Ngauv;Rafael Cubas

  238
  Citations

• Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis

  David G Dillon;David G Dillon;Deepti Gurdasani;Deepti Gurdasani;Johanna Riha;Johanna Riha;Kenneth Ekoru;Kenneth Ekoru

  228
  Citations

• Randomised controlled trials for Ebola: practical and ethical issues

  Clement Adebamowo;Oumou Bah-Sow;Fred Binka;Roberto Bruzzone

  215
  Citations

• A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa.

  Eduan Wilkinson;Eduan Wilkinson;Marta Giovanetti;Marta Giovanetti;Houriiyah Tegally;James E. San

  213
  Citations

• CLSI-derived hematology and biochemistry reference intervals for healthy adults in eastern and southern Africa

  Etienne Karita;Nzeera Ketter;Matt A. Price;Kayitesi Kayitenkore

  208
  Citations

• HIV and syphilis prevalence and associated risk factors among fishing communities of Lake Victoria, Uganda.

  Gershim Asiki;Juliet Mpendo;Andrew Abaasa;Collins Agaba

  198
  Citations

• High HIV incidence and socio-behavioral risk patterns in fishing communities on the shores of Lake Victoria, Uganda.

  Janet Seeley;Jessica Nakiyingi-Miiro;Anatoli Kamali;Juliet Mpendo

  190
  Citations

• Emergence of new SARS-CoV-2 Variant of Concern Omicron (B.1.1.529) - highlights Africa's research capabilities, but exposes major knowledge gaps, inequities of vaccine distribution, inadequacies in global COVID-19 response and control efforts

  Eskild Petersen;Francine Ntoumi;David S Hui;Aisha Abubakar

  179
  Citations

• Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort.

  Pontiano Kaleebu;Amanda Ross;Dilys Morgan;David Yirrell

  175
  Citations

• Virological response to a triple nucleoside/nucleotide analogue regimen over 48 weeks in HIV-1-infected adults in Africa

  P. Kaleebu;D. Pillay;A. S. Walker;V. Robertson

  174
  Citations

• Safety and Immunogenicity of a 2-Dose Heterologous Vaccination Regimen With Ad26.ZEBOV and MVA-BN-Filo Ebola Vaccines: 12-Month Data From a Phase 1 Randomized Clinical Trial in Uganda and Tanzania.

  Zacchaeus Anywaine;Hilary Whitworth;Hilary Whitworth;Pontiano Kaleebu;George Praygod

  171
  Citations

• Adenovirus-Based Vaccines: Comparison of Vectors from Three Species of Adenoviridae

  H. Chen;Z. Q. Xiang;Y. Li;R. K. Kurupati

  162
  Citations

• A KIR B centromeric region present in Africans but not Europeans protects pregnant women from pre-eclampsia

  Annettee Nakimuli;Olympe Anne Chazara;Susan E Hiby;Lydia Farrell

  161
  Citations

• Neutralization serotypes of human immunodeficiency virus type 1 field isolates are not predicted by genetic subtype. The WHO Network for HIV Isolation and Characterization.

  J Weber;E M Fenyö;S Beddows;P Kaleebu

  160
  Citations

• Transmitted HIV type 1 drug resistance among individuals with recent HIV infection in East and Southern Africa.

  Matt A. Price;Carole L. Wallis;Shabir Lakhi;Etienne Karita

  155
  Citations

• Efficacy and safety of dolutegravir or darunavir in combination with lamivudine plus either zidovudine or tenofovir for second-line treatment of HIV infection (NADIA): week 96 results from a prospective, multicentre, open-label, factorial, randomised, non-inferiority trial.

  Unknown

  153
  Citations

• The Glutamine-rich Region of the HIV-1 Tat Protein Is Involved in T-cell Apoptosis

  Grant R. Campbell;Eddy Pasquier;Jennifer Watkins;Veronique Bourgarel-Rey

  147
  Citations

• A year of genomic surveillance reveals how the SARS-CoV-2 pandemic unfolded in Africa

  Eduan Wilkinson;Marta Giovanetti;Marta Giovanetti;Houriiyah Tegally;James E San

  25
  Citations